NBAA Supports Senate Bills to Modernize Aviation Mental Health Protocols

NBAA Endorses New Senate Legislation to Modernize Aviation Mental Health Protocols

The National Business Aviation Association (NBAA) has officially thrown its support behind two pivotal bipartisan bills introduced in the United States Senate on November 20, 2025. These legislative measures, spearheaded by Senators Tammy Duckworth (D-IL) and John Hoeven (R-ND), aim to fundamentally reshape how the Federal Aviation Administration (FAA) approaches mental health and medical transparency for pilots and air traffic controllers. We view this development as a significant step toward dismantling the long-standing barriers that have historically discouraged aviation professionals from seeking necessary medical care.

For decades, the aviation industry has grappled with a “culture of silence” regarding mental health. Pilots and controllers have often avoided diagnosis or treatment due to the legitimate fear that disclosing such issues would result in the immediate and permanent loss of their medical certification, and by extension, their careers. The introduction of the Mental Health in Aviation Act and the Aviation Medication Transparency Act marks a legislative effort to prioritize safety by ensuring that professionals can seek help without the threat of professional ruin.

The NBAA’s endorsement highlights the industry’s collective recognition that the current system is outdated. By aligning with the recommendations of the recent Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee (ARC), these bills seek to modernize regulations, clear administrative backlogs, and provide clear guidance on medication. We are witnessing a shift from a punitive approach to one centered on support, transparency, and safety.

The Mental Health in Aviation Act

The first of the two measures, the Mental Health in Aviation Act, is designed to directly address the systemic hurdles within the FAA’s medical certification process. A primary component of this legislation is the mandate for the FAA to update its mental health guidance, encouraging early disclosure and treatment rather than penalizing it. The bill requires an annual review of the FAA’s “Special Issuance” Medical Certification process, ensuring that the protocols remain current with medical science and do not unnecessarily ground qualified pilots.

To support these operational changes, the legislation proposes significant financial investment. It allocates $15 million annually from fiscal years 2026 through 2029 to the FAA’s Office of Aerospace Medicine. This funding is specifically targeted at recruiting and training more Aviation Medical Examiners (AMEs) and specialists. The goal is to alleviate the severe backlog of medical cases, which has often left pilots in limbo for months or even years while awaiting certification decisions.

Furthermore, the bill recognizes that policy changes must be accompanied by cultural shifts. Consequently, it allocates $1.5 million annually over the same period for a public information campaign. This initiative aims to destigmatize mental health care within the aviation community, reassuring pilots and controllers that seeking help is a responsible safety decision, not a career-ending admission.

“It’s essential that we foster an environment where pilots, air traffic controllers and others feel safe to seek help without fear of retribution or repercussion.”, Ed Bolen, NBAA President and CEO.

The Aviation Medication Transparency Act

The second piece of legislation, the Aviation Medication Transparency Act, addresses the confusion surrounding permissible medical treatments. Currently, many aviation professionals struggle to determine which medications are compatible with flight status, leading to accidental disqualifications or, worse, individuals foregoing necessary treatment. This bill mandates that the FAA publish and annually update a user-friendly, public list of medications approved for use by pilots and air traffic controllers.

We note that the legislation requires this list to be explicit and categorical. Medications must be clearly labeled as “Can Be Safely Prescribed” or “Do Not Issue.” Additionally, the list must specify any required waiting periods or duty limitations associated with specific drugs. This level of transparency is intended to empower pilots to work proactively with their personal physicians, choosing treatments that effectively manage their health without jeopardizing their medical certification.

This move toward transparency is expected to reduce the administrative burden on both the FAA and aviation professionals. By removing the guesswork, the industry can prevent situations where pilots are grounded simply due to a lack of information regarding a prescription. It allows for a medical environment where physical and mental well-being are treated with equal importance.

Context: The Human Cost of Silence

The urgency behind these Senate bills, and their companion legislation in the House, is driven by tragic real-world events that have exposed the flaws in the current system. The industry was deeply shaken by the 2021 death of John Hauser, a 19-year-old student pilot at the University of North Dakota. Hauser died by suicide, leaving behind a note explaining that he felt unable to seek help for his depression because a diagnosis would have permanently revoked his pilot’s license. His tragedy became a catalyst for the “Pilot Mental Health Campaign,” underscoring the desperate need for reform.

Further emphasizing the safety risks of the status quo was the October 2023 incident involving Alaska Airlines Flight 2059. An off-duty pilot, riding in the cockpit jumpseat, attempted to shut down the aircraft’s engines mid-flight. Subsequent investigations revealed the pilot was in the midst of a mental health crisis, exacerbated by sleep deprivation and the use of psychedelics to cope with grief. He later stated that he had avoided seeking professional help for depression for years, specifically citing the FAA’s strict medical rules as the deterrent. This incident highlighted that discouraging treatment does not remove the risk; it merely hides it in the cockpit.

These events have galvanized lawmakers and industry leaders alike. Senators Duckworth and Hoeven have framed these bills not just as administrative updates, but as essential safety measures. By implementing the recommendations of the FAA’s Rulemaking Committee, the legislation aims to prevent future tragedies by ensuring that the individuals responsible for the safety of the national airspace system are healthy, supported, and monitored effectively.

Conclusion

The NBAA’s welcome of these Senate bills signals a unified industry front advocating for the well-being of aviation professionals. By addressing the twin challenges of stigma and bureaucratic opacity, the Mental Health in Aviation Act and the Aviation Medication Transparency Act promise a safer future for air travel. We are observing a critical pivot where the mental health of a pilot is viewed as a component of their fitness to fly, rather than a reason to ground them permanently.

As these bills progress through the legislative process, mirroring the advancements of H.R. 2591 and H.R. 2592 in the House, the focus will remain on implementation. The allocation of funds to clear backlogs and the creation of transparent medication lists are practical steps that will have immediate impacts. Ultimately, this legislation represents a commitment to a safety culture that values the human element of aviation as much as the mechanical.

FAQ

Question: What are the two new bills supported by the NBAA?
Answer: The NBAA supports the Mental Health in Aviation Act and the Aviation Medication Transparency Act, both introduced in the Senate on November 20, 2025.

Question: What is the main goal of the Mental Health in Aviation Act?
Answer: Its primary goal is to remove barriers that discourage pilots and controllers from seeking mental health care, modernize FAA regulations, and fund the recruitment of more Aviation Medical Examiners to clear backlogs.

Question: How does the Aviation Medication Transparency Act help pilots?
Answer: It requires the FAA to publish a clear, annually updated list of medications that are safe for flight (“Can Be Safely Prescribed”) versus those that are not, allowing pilots to make informed medical decisions without risking their certification.

Sources

• NBAA Press Release